GGrantIndex
← Leaderboards

David H Canaday

Case Western Reserve University

$7,031,026
Attributed
$11,008,194
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$11,008,194 · 7
VA$0 · 2

By mechanism

R01$9,241,295 · 3
R21$1,296,019 · 3
K08$470,880 · 1
I01$0 · 2

Top collaborators

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Response

Research focus

ResponseVaccinesAntibodiesImmunologicsInfectionVaccinationCd4 Positive T LymphocytesImmuneT-LymphocyteCessation Of LifeB-LymphocytesElderlyPersonsDefectMediatingCellular ImmunityInfluenza Virus VaccineInfluenzaBaseAdultInfluenza VaccinationMorbidity - Disease RateImmune ResponseInnovation

Grant awards (31)

Immunogenicity of recombinant zoster vaccine in Rheumatoid arthritis patients$0
I01 · FY2024 · VA · contact PI
Immunogenicity of recombinant zoster vaccine in Rheumatoid arthritis patients$0
I01 · FY2023 · VA · contact PI
Immunogenicity of recombinant zoster vaccine in Rheumatoid arthritis patients$0
I01 · FY2022 · VA · contact PI
Epidemiology, transmission and immunology of COVID-19 in nursing home residents$1,332,423
R01 · FY2021 · AI · contact PI
Immunogenicity of recombinant zoster vaccine in Rheumatoid arthritis patients$0
I01 · FY2021 · VA · contact PI
Epidemiology, transmission and immunology of COVID-19 in nursing home residents$1,008,129
R01 · FY2020 · AI · contact PI
Non-inferiority study of adjuvanted vs. high dose flu vaccine in residents of long term care$778,393
R01 · FY2020 · AI · contact PI
Non-inferiority study of adjuvanted vs. high dose flu vaccine in residents of long term care$798,632
R01 · FY2019 · AI · contact PI
Non-inferiority study of adjuvanted vs. high dose flu vaccine in residents of long term care$799,912
R01 · FY2018 · AI · contact PI
CD4+ T and B cell mechanisms of influenza vaccine non-responsiveness in older adu$444,759
R01 · FY2018 · AI · contact PI
CD4+ T and B cell mechanisms of influenza vaccine non-responsiveness in older adu$646,869
R01 · FY2017 · AI · contact PI
CD4+ T and B cell mechanisms of influenza vaccine non-responsiveness in older adu$454,879
R01 · FY2016 · AI · contact PI
CD4+ T and B cell mechanisms of influenza vaccine non-responsiveness in older adu$463,001
R01 · FY2015 · AI · contact PI
CD4+ T and B cell mechanisms of influenza vaccine non-responsiveness in older adu$470,090
R01 · FY2014 · AI · contact PI
Mechanisms of increased susceptibility to TB in HIV-Infected individuals$504,771
R01 · FY2013 · AI · contact PI
Mechanisms of increased susceptibility to TB in HIV-Infected individuals$551,240
R01 · FY2012 · AI · contact PI
Predictors of Immunologic Failure in Older Adults$0
I01 · FY2012 · VA · contact PI
Mechanisms of increased susceptibility to TB in HIV-Infected individuals$472,012
R01 · FY2011 · AI · contact PI
Predictors of Immunologic Failure in Older Adults$0
I01 · FY2011 · VA · contact PI
Mechanisms of increased susceptibility to TB in HIV-Infected individuals$516,185
R01 · FY2010 · AI · contact PI
Predictors of Immunologic Failure in Older Adults$0
I01 · FY2009 · VA · contact PI
Mechanisms of MHC-II antigen processing of HIV in macrophages and dendritic cells$189,456
R21 · FY2008 · AI · contact PI
Dysfuntional antigen presenting cell responses to influenza in geriatric individu$189,456
R21 · FY2008 · AI · contact PI
Dysfuntional antigen presenting cell responses to influenza in geriatric individu$231,750
R21 · FY2007 · AI · contact PI
Mechanisms of MHC-II antigen processing of HIV in macrophages and dendritic cells$231,750
R21 · FY2007 · AI · contact PI
Antigen Processing in HIV-infected Individuals$224,107
R21 · FY2006 · AI · contact PI
Antigen Processing in HIV-infected Individuals$229,500
R21 · FY2005 · AI
CD8+ T CELLS AND MYCOPLASMA TUBERCULOSIS$120,420
K08 · FY2003 · AI
CD8+ T CELLS AND MYCOPLASMA TUBERCULOSIS$120,420
K08 · FY2002 · AI
CD8+ T CELLS AND MYCOPLASMA TUBERCULOSIS$120,420
K08 · FY2001 · AI
CD8+ T CELLS AND MYCOPLASMA TUBERCULOSIS$109,620
K08 · FY2000 · AI